Patent Assignment
Reel/Frame 048029/0908
Assignment of Assignor's Interest
Recorded: 2018-10-24
Pages: 83
Assignor
OREXIGEN THERAPEUTICS, INC.
Executed: 2018-07-13
Assignee
NALPROPION PHARMACEUTICALS, INC.
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
Covered Property
(1)
Compositions and Methods for Reducing Food Cravings
Application:
15/411,585 →
Publication:
US 2017/0312269
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 24, 2017
From: MCKINNEY, ANTHONY A.; TOLLEFSON, GARY; COWLEY, MICHAEL A.
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041734/0789 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →